NCT07130721Not yet recruiting
Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients
Assessment of Blood Biomarkers (D-dimer and C-Reactive Protein) in Predicting Cardiovascular Complications Among Hemodialysis Patients: A Cross-Sectional Study
Source: ClinicalTrials.gov · Last updated 19 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to assess whether two blood markers - C-reactive protein (CRP) and D-dimer - can help predict cardiovascular complications in patients undergoing regular hemodialysis. Cardiovascular disease is a common and serious problem in dialysis patients, and early detection is important. the study will include 100 adult patients from the Hemodialysis Unit at Assiut University Hospital. Participants will be divided into two groups: those with and those without known heart disease. Each participant will have a one-time blood test to measure CRP and D-dimer levels. In addition, an electrocardiogram (ECG) will be done once to check for signs of heart problems.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 9 Aug 2025
- Start date
- 1 Nov 2025
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- Assiut University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07130721
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Nov 2025 to the primary completion date, 1 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Acute or recent infection (within the past 4 weeks)
- Use of anticoagulant or antiplatelet therapy
- Active malignancy
- Autoimmune or chronic inflammatory disease
- Known bleeding or thrombotic disorders
- Pregnancy
Who the study is looking for
- Adults aged ≥18 years
- On regular hemodialysis for at least 3 months
- Able and willing to provide informed consent
- Group I: Hemodialysis patients with no clinically documented cardiovascular disease
- Group II: Hemodialysis patients with confirmed cardiovascular disease (by medical records, ECGs, echocardiography, or documented hospital admissions)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assiut University hospital Coordinator of this site? Confirm its status | Asyut | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.